Hypochlorhydria and achlorhydria are associated with false-positive secretin stimulation testing for zollinger-ellison syndrome

Pancreas

Volumn 42, Issue 6, 2013, Pages 932-936

  Shah, Pari ^a   Singh, Maneesh H ^b   Yang, Yu Xiao ^b   Metz, David C ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

achlorhydria; gastrin; proton pump inhibitor; secretin; Zollinger Ellison syndrome

Indexed keywords

ESOMEPRAZOLE; GASTRIN; LANSOPRAZOLE; OMEPRAZOLE; RABEPRAZOLE; SECRETIN;

ACHLORHYDRIA; ADOLESCENT; ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FALSE POSITIVE RESULT; FEMALE; GASTRIN BLOOD LEVEL; GASTRINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ZOLLINGER ELLISON SYNDROME;

ACHLORHYDRIA; ADOLESCENT; ADULT; AGED; ANTI-ULCER AGENTS; ESOMEPRAZOLE; FALSE POSITIVE REACTIONS; FEMALE; GASTRIC ACID; HUMANS; LANSOPRAZOLE; MALE; MIDDLE AGED; OMEPRAZOLE; RABEPRAZOLE; SECRETIN; SENSITIVITY AND SPECIFICITY; STOMACH; YOUNG ADULT; ZOLLINGER-ELLISON SYNDROME;

EID: 84880688537     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182847b2e     Document Type: Article

References (33)

1. Zollinger RM, Ellison EH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg. 1955;142(4):709-723; discussion, 724-708.
2. Gregory RA, Tracy HJ, French JM, et al. Extraction of a gastrin-like substance from a pancreatic tumour in a case of Zollinger-Ellison syndrome. Lancet. 1960;1(7133):1045-1048.
3. Jensen RT, Gardner JD, Raufman JP, et al. Zollinger-Ellison syndrome: current concepts and management. Ann Intern Med. 1983;98(1):59-75.
4. McGuigan JE, Trudeau WL. Immunochemical measurement of elevated levels of gastrin in the serum of patients with pancreatic tumors of the Zollinger-Ellison variety. N Engl J Med. 1968;278(24):1308-1313.
5. Isenberg JI, Walsh JH, Grossman MI. Zollinger-Ellison syndrome. Gastroenterology. 1973;65(1):140-165.
6. Wolfe MM, Reel GM, McGuigan JE. Inhibition of gastrin release by secretin is mediated by somatostatin in cultured rat antral mucosa. J Clin Invest. 1983;72(5):1586-1593.
7. Metz DC, Starr JA. A retrospective study of the usefulness of acid secretory testing. Aliment Pharmacol Ther. 2000;14(1):103-111.
8. Maton P, Dayal Y. Clinical implications of hypergastrinemia. In: Zakim D, Dannenberg A, eds. Peptic Ulcer Disease and Other Acid-Related Disorders. Armonk, NY: Academic Research Associates, Inc.; 1991:213.
9. Klein K. Gastric secretory testing. In: Drossman D, ed. Manual of Gastroenterologic Procedures. New York, NY: Raven Press; 1993:61.
10. Frucht H, Howard JM, Slaff JI, et al. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study. Ann Intern Med. 1989;111(9):713-722.
11. Hansky J, Soveny C, Korman MG. Effect of secretin on serum gastrin as measured by immunoassay. Gastroenterology. 1971;61(1):62-68.
12. Isenberg JI, Walsh JH, Passaro E Jr, et al. Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome. Gastroenterology. 1972;62(4):626-631.
13. Kolts BE, Herbst CA, McGuigan JE. Calcium and secretin-stimulated gastrin release in the Zollinger-Ellison syndrome. Ann Intern Med. 1974;81(6):758-762.
14. McGuigan JE, Wolfe MM. Secretin injection test in the diagnosis of gastrinoma. Gastroenterology. 1980;79(6):1324-1331.
15. Imamura M, Adachi H, Takahashi K, et al. Gastrin release from gastrinoma cells stimulated with secretin. Dig Dis Sci. 1982;27(12):1130-1136.
16. Long SH, Berna MJ, Thill M, et al. Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results. J Clin Endocrinol Metab. 2007;92(11):4394-4402.
17. Berna MJ, Hoffmann KM, Long SH, et al. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features. Medicine (Baltimore). 2006;85(6):331-364.
18. Corleto VD, Annibale B, Gibril F, et al. Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome? Aliment Pharmacol Ther. 2001;15(10):1555-1561.
19. Goldman JA, Blanton WP, Hay DW, et al. False-positive secretin stimulation test for gastrinoma associated with the use of proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2009;7(5):600-602.
20. Poitras P, Gingras MH, Rehfeld JF. The Zollinger-Ellison syndrome: dangers and consequences of interrupting antisecretory treatment. Clin Gastroenterol Hepatol. 2012;10(2):199-202.
21. Brady CE 3rd, Utts SJ, Dev J. False-positive gastrin rises after secretin injection. J Lab Clin Med. 1985;106(4):461-462.
22. Feldman M, Schiller LR, Walsh JH, et al. Positive intravenous secretin test in patients with achlorhydria-related hypergastrinemia. Gastroenterology. 1987;93(1):59-62.
23. Wollmuth RL, Wagonfeld JB. False-positive secretin test. Ann Intern Med. 1978;88(5):718-719.
24. Kuiper P, Biemond I, Masclee AA, et al. Diagnostic efficacy of the secretin stimulation test for the Zollinger-Ellison syndrome: an intra-individual comparison using different dosages in patients and controls. Pancreatology. 2010;10(1):14-18.
25. Metz DC, Buchanan M, Purich E, et al. A randomized controlled crossover study comparing synthetic porcine and human secretins with biologically derived porcine secretin to diagnose Zollinger-Ellison Syndrome. Aliment Pharmacol Ther. 2001;15(5):669-676.
26. Solcia E, Vassallo G, Sampietro R. Endocrine cells in the antro-pyloric mucosa of the stomach. Z Zellforsch Mikrosk Anat. 1967;81(4): 474-486.
27. Walsh JH, Grossman MI. Gastrin (second of two parts). N Engl J Med. 1975;292(26):1377-1384.
28. Tatsuta M, Itoh T, Okuda S, et al. Effect of fundusectomy on serum and antral gastrin levels in rats. Gastroenterology. 1977;72(1):78-81.
29. Hattori Y, Imamura M, Tobe T. Gastrin release from antral G cells stimulated with secretin. Am J Gastroenterol. 1992;87(2):195-200.
30. Brady CE 3rd, Hyatt JR, Utts SJ. Is the gastrin response to secretin provocation a function of antral G-cell mass? Results in the hypergastrinemia of acid hyposecretion. J Clin Gastroenterol. 1989;11(1):27-32.
31. Raines D, Chester M, Diebold AE, et al. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans. Pancreas. 2012;41(4):508-511.
32. Ito T, Igarashi H, Jensen RT. Serum pancreastatin: the long sought universal, sensitive, specific tumor marker for neuroendocrine tumors? Pancreas. 2012;41(4):505-507.
33. Metz DC. Diagnosis of the Zollinger-Ellison syndrome. Clin Gastroenterol Hepatol. 2012;10(2):126-130.